Michał Kunc

700 total citations
51 papers, 431 citations indexed

About

Michał Kunc is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Michał Kunc has authored 51 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in Michał Kunc's work include Renal cell carcinoma treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and HER2/EGFR in Cancer Research (4 papers). Michał Kunc is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and HER2/EGFR in Cancer Research (4 papers). Michał Kunc collaborates with scholars based in Poland, Austria and Germany. Michał Kunc's co-authors include Wojciech Biernat, Piotr Czapiewski, Elżbieta Senkus, Johannes Haybaeck, Jacek M. Witkowski, Rafał Pęksa, Marta Popęda, Krzysztof Sworczak, Ewa Bień and Ewa Iżycka‐Świeszewska and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Journal of the Operational Research Society.

In The Last Decade

Michał Kunc

43 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michał Kunc Poland 14 205 135 109 90 67 51 431
Sebastian Costa France 10 171 0.8× 127 0.9× 122 1.1× 35 0.4× 47 0.7× 14 413
Jiang Qian China 14 98 0.5× 54 0.4× 132 1.2× 57 0.6× 45 0.7× 53 465
Stephen Brady United States 7 153 0.7× 63 0.5× 122 1.1× 74 0.8× 57 0.9× 7 397
Ilze Štrumfa Latvia 13 151 0.7× 79 0.6× 171 1.6× 51 0.6× 107 1.6× 55 580
Ehab Husain United Kingdom 11 135 0.7× 67 0.5× 118 1.1× 57 0.6× 129 1.9× 25 398
Johannes Doescher Germany 14 248 1.2× 149 1.1× 109 1.0× 78 0.9× 54 0.8× 44 488
Adam G. Baseman United States 7 129 0.6× 105 0.8× 163 1.5× 149 1.7× 74 1.1× 8 423
J.C. Vaillant France 7 279 1.4× 128 0.9× 80 0.7× 92 1.0× 39 0.6× 15 622
Terri Woo United States 7 129 0.6× 114 0.8× 135 1.2× 31 0.3× 85 1.3× 8 394
Emilie Lavergne France 14 266 1.3× 73 0.5× 191 1.8× 157 1.7× 50 0.7× 23 617

Countries citing papers authored by Michał Kunc

Since Specialization
Citations

This map shows the geographic impact of Michał Kunc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Kunc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Kunc more than expected).

Fields of papers citing papers by Michał Kunc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michał Kunc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Kunc. The network helps show where Michał Kunc may publish in the future.

Co-authorship network of co-authors of Michał Kunc

This figure shows the co-authorship network connecting the top 25 collaborators of Michał Kunc. A scholar is included among the top collaborators of Michał Kunc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michał Kunc. Michał Kunc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kunc, Michał, et al.. (2025). TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 26(14). 6847–6847.
2.
Sharma, Sumit, Michał Kunc, Rafał Pęksa, et al.. (2025). Biology of renal cancer tumor thrombus - towards the personalized approach. Critical Reviews in Oncology/Hematology. 211. 104731–104731. 1 indexed citations
3.
Krawczyk, Małgorzata, Bernarda Kazanowska, Maryna Krawczuk‐Rybak, et al.. (2025). Prognostic Role of Systemic Inflammatory Markers in Pediatric Soft‐Tissue Sarcoma: A Multicenter Study of 213 Patients. Pediatric Blood & Cancer. 72(7). e31701–e31701.
4.
Kunc, Michał, Maria Maksymowicz, M Łapiński, et al.. (2025). A case of prolonged adrenal insufficiency following osilodrostat discontinuation with a review of the literature. Endocrine Journal. 73(1). 87–92. 1 indexed citations
5.
Pęksa, Rafał, et al.. (2024). Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes. Biomedicines. 12(4). 763–763. 22 indexed citations
6.
Karlsson, Fredrik, et al.. (2023). Testicular teratoma with nephroblastoma in an adult – case report and literature review. Współczesna Onkologia. 27(1). 60–63.
7.
8.
Wojtyś, Małgorzata, et al.. (2022). Benign Metastasizing Leiomyoma of the Lung: Diagnostic Process and Treatment Based on Three Case Reports and a Review of the Literature. Biomedicines. 10(10). 2465–2465. 7 indexed citations
9.
Zapała, Łukasz, Michał Kunc, Sumit Sharma, et al.. (2022). Evaluation of PD-L1 (E1L3N, 22C3) expression in venous tumor thrombus is superior to its assessment in renal tumor in predicting overall survival in renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 40(5). 200.e1–200.e10. 2 indexed citations
10.
Zapała, Łukasz, Michał Kunc, Sumit Sharma, et al.. (2022). Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus. Journal of Cancer Research and Clinical Oncology. 149(7). 4131–4139. 13 indexed citations
11.
12.
Zapała, Łukasz, Michał Kunc, Sumit Sharma, Wojciech Biernat, & Piotr Radziszewski. (2021). Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus. Diagnostics. 11(11). 2159–2159. 8 indexed citations
13.
Kunc, Michał, Marta Popęda, Wojciech Biernat, & Elżbieta Senkus. (2021). Lost but Not Least—Novel Insights into Progesterone Receptor Loss in Estrogen Receptor-Positive Breast Cancer. Cancers. 13(19). 4755–4755. 13 indexed citations
14.
Zapała, Łukasz, Sumit Sharma, Michał Kunc, et al.. (2021). Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus. Journal of Clinical Medicine. 10(17). 3852–3852. 4 indexed citations
15.
Kunc, Michał, Marta Popęda, Anna Szałkowska, et al.. (2020). microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study. Diagnostics. 10(9). 617–617. 8 indexed citations
16.
Kunc, Michał, et al.. (2020). Immunohistochemical evaluation of mismatch repair proteins and p53 expression in extrauterine carcinosarcoma/sarcomatoid carcinoma. Współczesna Onkologia. 24(1). 1–4. 4 indexed citations
17.
Kunc, Michał, et al.. (2019). Who Is a Pathologist According to Oncology Patients and Internet Users? A Survey Study. Journal of Cancer Education. 36(2). 370–376. 2 indexed citations
18.
Kunc, Michał & Wojciech Biernat. (2019). Carcinoma Cuniculatum of the Lower Leg: A Case Report and Proposed Diagnostic Criteria. American Journal of Dermatopathology. 41(11). 855–857. 3 indexed citations
19.
Krawczyk, Małgorzata, Michał Kunc, Ewa Iżycka‐Świeszewska, et al.. (2019). Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma. Biomarkers. 24(6). 538–548. 13 indexed citations
20.
Kunc, Michał, Wojciech Biernat, & Elżbieta Senkus. (2018). Estrogen receptor-negative progesterone receptor-positive breast cancer – “Nobody's land“ or just an artifact?. Cancer Treatment Reviews. 67. 78–87. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Costa Breakdown of academic impact, for papers by Jiang Qian Breakdown of academic impact, for papers by Stephen Brady Breakdown of academic impact, for papers by Ilze Štrumfa Breakdown of academic impact, for papers by Ehab Husain Breakdown of academic impact, for papers by Johannes Doescher Breakdown of academic impact, for papers by Adam G. Baseman Breakdown of academic impact, for papers by J.C. Vaillant Breakdown of academic impact, for papers by Terri Woo Breakdown of academic impact, for papers by Emilie Lavergne
Rankless by CCL
2026